Accès gratuit
Biologie Aujourd’hui
Volume 213, Numéro 1-2, 2019
Page(s) 35 - 41
Publié en ligne 5 juillet 2019
  • Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38, 1-211. [Google Scholar]
  • Bose, P., Karsan, N., Goadsby, P.J. (2018). The migraine postdrome. Continuum (Minneap Minn), 24, 1023-1031. [PubMed] [Google Scholar]
  • Disease, G.B.D., Injury, I., Prevalence, C. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390, 1211-1259. [CrossRef] [PubMed] [Google Scholar]
  • Donnet, A., Emery, C., Aly, S., Allaf, B., Cayre, F., Mahieu, N., Gourmelen, J., Lévy, P., Fagnani, F. (2019). Migraine burden and costs in France: a nationwide claims database analysis of triptan users. J Med Econ, 1-9. [Google Scholar]
  • Goadsby, P.J., Holland, P.R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., Akerman, S. (2017). Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev, 97, 553-622. [Google Scholar]
  • Hepp, Z., Dodick, D.W., Varon, S.F., Chia, J., Matthew, N., Gillard, P., Hansen, R.N., Devine, E.B. (2017). Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia, 37, 470-485. [CrossRef] [PubMed] [Google Scholar]
  • Jackson, J.L., Cogbill, E., Santana-Davila, R., Eldredge, C., Collier, W., Gradall, A., Sehgal, N., Kuester, J. (2015). A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One, 10, e0130733. [CrossRef] [PubMed] [Google Scholar]
  • Jarvis, S., Dassan, P., Piercy, C.N. (2018). Managing migraine in pregnancy. BMJ, 360, k80. [Google Scholar]
  • Karsan, N., Bose, P., Goadsby, P.J. (2018). The migraine premonitory phase. Continuum (Minneap Minn) , 24, 996-1008. [PubMed] [Google Scholar]
  • Lampl, C., Buzath, A., Klinger, D., Neumann, K. (1999). Lamotrigine in the prophylactic treatment of migraine aura − a pilot study. Cephalalgia, 19, 58-63. [CrossRef] [PubMed] [Google Scholar]
  • Lampl, C., Thomas, H., Stovner, L.J., Tassorelli, C., Katsarava, Z., Lainez, J.M., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Andrée, C., Steiner, T.J. (2016). Interictal burden attributable to episodic headache: findings from the Eurolight project. J Headache Pain, 17, 9. [CrossRef] [PubMed] [Google Scholar]
  • Lantéri-Minet, M., Radat, F., Chautard, M.H., Lucas, C. (2005). Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain, 118, 319-326. [CrossRef] [PubMed] [Google Scholar]
  • Lantéri-Minet, M., Massiou, H., Romatet, S., Barba, A., Lucas, C., Allaf, B. (2011). An instrument to assess patient perceptions of satisfaction with acute migraine treatment (EXPERT Study). Headache, 51, 590-601. [CrossRef] [PubMed] [Google Scholar]
  • Lantéri-Minet, M., Valade, D., Géraud, G., Lucas, C., Donnet, A. (2014). Revised French guidelines for the diagnosis and management of migraine in adults and children. J Headache Pain, 15, 2. [CrossRef] [PubMed] [Google Scholar]
  • Linde, M., Gustavsson, A., Stovner, L.J., Steiner, T.J., Barré, J., Katsarava, Z., Lainez, J.M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., Andrée, C. (2012). The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol, 19, 703-711. [CrossRef] [PubMed] [Google Scholar]
  • Lipton, R.B., Bigal, M.E., Diamond, M., Freitag, F., Reed, M.L., Stewart, W.F., Group, A.A. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 68, 343-349. [Google Scholar]
  • Mathew, N.T., Jaffri, S.F. (2009). A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache, 49, 1466-1478. [CrossRef] [PubMed] [Google Scholar]
  • Olsen, T.S. (1995). Pathophysiology of the migraine aura: the spreading depression theory. Brain , 118(Pt 1), 307-308. [CrossRef] [PubMed] [Google Scholar]
  • Rainero, I., Vacca, A., Govone, F., Gai, A., Pinessi, L., Rubino, E. (2018). Migraine: genetic variants and clinical phenotypes. Curr Med Chem. PMID: 30027842. [Google Scholar]
  • Russell, M.B., Ducros, A. (2011). Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol, 10, 457-470. [CrossRef] [PubMed] [Google Scholar]
  • Stovner, L.J., Zwart, J.A., Hagen, K., Terwindt, G.M., Pascual, J. (2006). Epidemiology of headache in Europe. Eur J Neurol, 13, 333-345. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.